Pivot Pharmaceuticals Inc. (PVOTF) financial statements (2020 and earlier)

Company profile

Business Address 1275 WEST 6TH AVENUE
VANCOUVER, BC V6H 1A6
State of Incorp. BC
Fiscal Year End January 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

1/31/2019
1/31/2018
1/31/2017
1/31/2016
1/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7565112721
Cash and cash equivalents7565112721
Prepaid expense1238517320
Other undisclosed current assets44    
Total current assets:2421491301031
Noncurrent Assets
Property, plant and equipment4   0
Intangible assets, net (including goodwill)8,350235   
Intangible assets, net (excluding goodwill)8,350235   
Deposits noncurrent assets  33 
Total noncurrent assets:8,354235330
TOTAL ASSETS:8,5963841331061
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Debt3,498200275  
Derivative instruments and hedges, liabilities  313 15
Due to related parties330102338 
Other undisclosed current liabilities  997  
Total current liabilities:3,8282101,6073815
Noncurrent Liabilities
Other undisclosed liabilities1,258219 39741
Total liabilities:5,0864291,60743556
Stockholders' equity
Stockholders' equity attributable to parent, including:3,510(45)(1,474)(329)(55)
Common stock21,3408,2647,3287,0543,471
Additional paid in capital16,99911,81611,2114,575262
Accumulated other comprehensive income123594585617225
Accumulated deficit(34,963)(20,719)(20,598)(12,591)(4,012)
Other undisclosed stockholders' equity attributable to parent10  16 
Total stockholders' equity:3,510(45)(1,474)(329)(55)
TOTAL LIABILITIES AND EQUITY:8,5963841331061

Income statement (P&L) ($ in thousands)

1/31/2019
1/31/2018
1/31/2017
1/31/2016
1/31/2015
Revenues
(Financial Services Revenue)
 247   
Cost of revenue
(Cost of Goods and Services Sold)
(9)(303)(4,119)(2,268)(3)
Gross profit:(9)(57)(4,119)(2,268)(3)
Operating expenses(6,844)(1,049)(6,024)(8,593)(117)
Other undisclosed operating income9574,1192,2683
Operating loss:(6,844)(1,049)(6,024)(8,593)(117)
Interest and debt expense(391)(27)(12) (65)
Loss from continuing operations before income taxes:(7,235)(1,077)(6,035)(8,593)(182)
Income tax expense (benefit)  (1,383)(1,208)47
Loss before gain (loss) on sale of properties:(7,235)(1,077)(7,419)(9,801)(136)
Other undisclosed net income (loss)  9801,614(839)
Net loss:(7,235)(1,077)(6,439)(8,187)(975)
Other undisclosed net income (loss) attributable to parent(1,911)955160(392)(154)
Net loss available to common stockholders, diluted:(9,146)(121)(6,278)(8,578)(1,129)

Comprehensive Income ($ in thousands)

1/31/2019
1/31/2018
1/31/2017
1/31/2016
1/31/2015
Net loss:(7,235)(1,077)(6,439)(8,187)(975)
Comprehensive loss:(7,235)(1,077)(6,439)(8,187)(975)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1,788)964 (56) 
Comprehensive loss, net of tax, attributable to parent:(9,023)(112)(6,439)(8,242)(975)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: